Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Somerset Therapeutics, LLC

NDC labeler code: 70069

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

186Products (NDC)

Prescription medicines

Show the other 38 medicines

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
July 28, 2026ANDA215260 Sugammadex
SUGAMMADEX SODIUM
Tamarang
June 4, 2026ANDA219604 Dalbavancin
DALBAVANCIN HYDROCHLORIDE
Be Pharms
June 3, 2026ANDA220137 Tofacitinib
TOFACITINIB CITRATE
Somerset Theraps LLC
May 27, 2026ANDA219529 Carboprost tromethamine
CARBOPROST TROMETHAMINE
Somerset Theraps LLC
May 13, 2026ANDA220068 Foscarnet sodium
FOSCARNET SODIUM
Caplin
March 16, 2026ANDA218984 Acamprosate calcium
ACAMPROSATE CALCIUM
Somerset Theraps LLC
January 29, 2026ANDA218798 Rilpivirine hydrochloride
RILPIVIRINE, RILPIVIRINE HYDROCHLORIDE
Somerset Theraps LLC
January 20, 2026ANDA219983 Sacubitril and valsartan
SACUBITRIL AND VALSARTAN
Somerset Theraps LLC
January 14, 2026ANDA219638 Eltrombopag
ELTROMBOPAG OLAMINE
Somerset Theraps LLC
December 5, 2025ANDA219096 Acetaminophen
ACETAMINOPHEN
Caplin
October 22, 2025ANDA220243 Nicardipine
NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Caplin
September 18, 2025ANDA219826 Sodium acetate
SODIUM ACETATE
Somerset Theraps LLC
September 2, 2025ANDA219170 Milrinone lactate
MILRINONE LACTATE IN DEXTROSE 5%
Caplin
June 24, 2025ANDA219078 Prucalopride
PRUCALOPRIDE SUCCINATE
Somerset Therap
May 20, 2025ANDA217453 Azacitidine
AZACITIDINE
Somerset Theraps LLC
May 13, 2025ANDA219168 Haloperidol decanoate
HALOPERIDOL DECANOATE
Caplin
February 26, 2025ANDA215228 Dihydroergotamine mesylate
DIHYDROERGOTAMINE MESYLATE
Somerset Theraps LLC
February 14, 2025ANDA215617 Phenylephrine
PHENYLEPHRINE HYDROCHLORIDE
Somerset Theraps LLC
February 12, 2025ANDA219194 Acetylcysteine
ACETYLCYSTEINE
Somerset Theraps LLC
February 11, 2025ANDA215004 Dorzolamide hydrochloride
DORZOLAMIDE HYDROCHLORIDE
Somerset Theraps LLC
January 30, 2025ANDA219302 Buprenorphine
BUPRENORPHINE HYDROCHLORIDE
Somerset Theraps LLC
January 16, 2025ANDA219562 Levetiracetam
LEVETIRACETAM IN SODIUM CHLORIDE
Caplin
January 14, 2025ANDA208909 Nitrofurantoin
NITROFURANTOIN
Somerset Theraps LLC
December 20, 2024ANDA217227 Tetracaine hydrochloride
TETRACAINE HYDROCHLORIDE
Somerset Theraps LLC
December 17, 2024ANDA218133 Calcium chloride
CALCIUM CHLORIDE 10%
Somerset
Show the other 75 applications
ApprovedApplicationMedicineSponsor
November 29, 2024ANDA215005 Atropine
ATROPINE SULFATE
Somerset Theraps LLC
November 14, 2024ANDA209698 Moxifloxacin
MOXIFLOXACIN HYDROCHLORIDE
Somerset Theraps LLC
November 1, 2024ANDA214332 Dicyclomine hydrochloride
DICYCLOMINE HYDROCHLORIDE
Somerset Theraps LLC
November 1, 2024ANDA214333 Dicyclomine hydrochloride
DICYCLOMINE HYDROCHLORIDE
Somerset Theraps LLC
October 16, 2024ANDA216152 Zinc chloride
ZINC CHLORIDE
Somerset
October 15, 2024ANDA216328 Ofloxacin
OFLOXACIN
Somerset Theraps LLC
October 10, 2024ANDA216654 Timolol
TIMOLOL
Somerset
October 9, 2024ANDA214960 Lacosamide
LACOSAMIDE
Somerset Theraps LLC
September 24, 2024ANDA218112 Dexmedetomidine
DEXMEDETOMIDINE HYDROCHLORIDE
Somerset
September 23, 2024ANDA217228 Travoprost ophthalmic solution
TRAVOPROST
Somerset Theraps LLC
September 19, 2024ANDA216049 Nalbuphine hydrochloride
NALBUPHINE HYDROCHLORIDE
Somerset Theraps LLC
September 19, 2024ANDA216050 Nalbuphine hydrochloride
NALBUPHINE HYDROCHLORIDE
Somerset Theraps LLC
September 16, 2024ANDA210640 Timolol
TIMOLOL MALEATE
Somerset Theraps LLC
September 13, 2024ANDA212257 Prochlorperazine
PROCHLORPERAZINE EDISYLATE
Somerset Theraps LLC
September 10, 2024ANDA216114 Brimonidine tartrate and timolol maleate
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Somerset
September 9, 2024ANDA218109 Cabergoline
CABERGOLINE
Somerset Theraps LLC
August 14, 2024ANDA217770 Bepotastine
BEPOTASTINE BESILATE
Somerset Theraps LLC
August 9, 2024ANDA215816 Proparacaine hydrochloride
PROPARACAINE HYDROCHLORIDE
Somerset Theraps LLC
August 9, 2024ANDA216906 Brimonidine tartrate
BRIMONIDINE TARTRATE
Somerset Theraps LLC
August 5, 2024ANDA211572 Polymyxin b sulfate and trimethoprim sulfate
TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE
Somerset Theraps LLC
August 1, 2024ANDA213597 Ofloxacin
OFLOXACIN
Somerset
July 17, 2024ANDA216135 Zinc sulfate
ZINC SULFATE
Somerset Theraps LLC
July 11, 2024ANDA217726 Potassium phosphates
POTASSIUM PHOSPHATES
Somerset Theraps LLC
July 3, 2024ANDA215969 Atropine
ATROPINE SULFATE
Somerset Theraps LLC
July 3, 2024ANDA216653 Timolol
TIMOLOL MALEATE
Somerset Theraps LLC
July 3, 2024ANDA217764 Timolol
TIMOLOL MALEATE
Somerset
July 1, 2024ANDA215618 Atropine
ATROPINE SULFATE
Somerset Theraps LLC
June 7, 2024ANDA218397 Acetylcysteine
ACETYLCYSTEINE
Somerset Theraps LLC
April 30, 2024ANDA216113 Cupric chloride
CUPRIC CHLORIDE
Somerset
April 29, 2024ANDA217791 Atropine
ATROPINE SULFATE
Somerset
March 6, 2024ANDA218021 Hydroxyurea
HYDROXYUREA
Qilu
November 20, 2023ANDA217792 Bupivacaine hydrochloride
BUPIVACAINE HYDROCHLORIDE
Somerset
October 19, 2023ANDA217689 Calcium gluconate
CALCIUM GLUCONATE
Somerset
October 11, 2022ANDA211898 Bortezomib
BORTEZOMIB
Somerset Theraps LLC
May 25, 2022ANDA211899 Pemetrexed
PEMETREXED DISODIUM
Somerset Theraps LLC
February 25, 2022ANDA216146 Ephedrine sulfate
EPHEDRINE SULFATE
Gland
January 27, 2022ANDA213467 Potassium chloride
POTASSIUM CHLORIDE
Granules
July 13, 2021ANDA213998 Sumatriptan
SUMATRIPTAN SUCCINATE
Caplin
April 20, 2021ANDA213074 Neostigmine methylsulfate
NEOSTIGMINE METHYLSULFATE
Caplin
April 16, 2021ANDA214380 Milrinone lactate
MILRINONE LACTATE
Caplin
November 18, 2020ANDA213859 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Guangzhou Novaken
June 11, 2020ANDA213318 Phenylephrine
PHENYLEPHRINE HYDROCHLORIDE
Caplin
January 31, 2020ANDA213306 Valganciclovir
VALGANCICLOVIR HYDROCHLORIDE
Granules
January 15, 2020ANDA211589 Succinylcholine
SUCCINYLCHOLINE CHLORIDE
Somerset Theraps LLC
December 12, 2019ANDA207524 Tropicamide
TROPICAMIDE
Somerset Theraps LLC
November 25, 2019ANDA210384 Pilocarpine hydrochloride
PILOCARPINE HYDROCHLORIDE
Somerset Theraps LLC
July 12, 2019ANDA210558 Isosulfan blue
ISOSULFAN BLUE
Somerset Theraps LLC
June 26, 2019ANDA212231 Sulfamethoxazole and trimethoprim
SULFAMETHOXAZOLE AND TRIMETHOPRIM
Somerset
June 25, 2019ANDA207523 Dorzolamide hydrochloride and timolol maleate
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Somerset
June 19, 2019ANDA207601 Bimatoprost
BIMATOPROST
Somerset Theraps LLC
May 10, 2019ANDA211036 Dexamethasone
DEXAMETHASONE SODIUM PHOSPHATE
Somerset Theraps LLC
April 24, 2019ANDA209132 Cisatracurium besylate
CISATRACURIUM BESYLATE
Somerset
March 29, 2019ANDA207411 Azelastine hydrochloride
AZELASTINE HYDROCHLORIDE
Somerset Theraps LLC
March 20, 2019ANDA211705 Glycopyrrolate
GLYCOPYRROLATE
Caplin
March 11, 2019ANDA208992 Brimonidine tartrate
BRIMONIDINE TARTRATE
Somerset Theraps LLC
February 20, 2019ANDA206791 Cisatracurium besylate
CISATRACURIUM BESYLATE PRESERVATIVE FREE
Somerset Theraps LLC
December 18, 2018ANDA209429 Cyanocobalamin
CYANOCOBALAMIN
Somerset Theraps LLC
October 12, 2018ANDA211433 Clonidine
CLONIDINE HYDROCHLORIDE
Somerset Theraps LLC
August 17, 2018ANDA210882 Sodium nitroprusside
SODIUM NITROPRUSSIDE
Somerset Theraps LLC
July 3, 2018ANDA209101 Haloperidol decanoate
HALOPERIDOL DECANOATE
Somerset Theraps LLC
June 18, 2018ANDA211015 Verapamil hydrochloride
VERAPAMIL HYDROCHLORIDE
Somerset Theraps LLC
June 18, 2018ANDA211035 Verapamil hydrochloride
VERAPAMIL HYDROCHLORIDE
Somerset
June 15, 2018ANDA207636 Ropivacaine hydrochloride
ROPIVACAINE HYDROCHLORIDE
Somerset Theraps LLC
June 8, 2018ANDA207521 Dexamethasone
DEXAMETHASONE SODIUM PHOSPHATE
Somerset
April 19, 2018ANDA207442 Dexamethasone
DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE
Somerset Theraps LLC
August 8, 2017ANDA207633 Naloxone hydrochloride
NALOXONE HYDROCHLORIDE
Somerset Theraps LLC
July 31, 2017ANDA207522 Methocarbamol
METHOCARBAMOL
Somerset Theraps LLC
July 26, 2017ANDA207634 Naloxone hydrochloride
NALOXONE HYDROCHLORIDE
Somerset Theraps LLC
June 28, 2017ANDA207444 Tobramycin
TOBRAMYCIN
Somerset Theraps LLC
June 23, 2017ANDA207639 Glycopyrrolate
GLYCOPYRROLATE
Somerset Theraps LLC
December 11, 2015ANDA206503 Cyanocobalamin
CYANOCOBALAMIN
Somerset Theraps LLC
October 31, 2011ANDA090951 Epinastine hydrochloride
EPINASTINE HYDROCHLORIDE
Somerset Theraps LLC
May 4, 2011ANDA090316 Midazolam
MIDOZALAM HYDROCHLORIDE
Onesource Specialty
March 22, 2011ANDA201786 Latanoprost
LATANOPROST
Somerset
November 29, 2010ANDA090315 Midazolam
MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
Onesource Specialty

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. February 4, 2026 · Class II · Ongoing · D-0398-2026 · Dexamethasone

    Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

    Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 7006

2025

  1. November 26, 2025 · Class III · Ongoing · D-0236-2026 · Cisatracurium besylate

    Subpotent product:out of specification assay results observed during long term stability testing.

    Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 700

  2. November 26, 2025 · Class III · Ongoing · D-0237-2026 · Cisatracurium besylate

    Subpotent product:out of specification assay results observed during long term stability testing.

    Cisatracurium Besylate Injection USP, 200mg/20mL*(10mg/mL), 10 x 20 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single dose 20mL vial NDC 70

  3. November 26, 2025 · Class III · Ongoing · D-0238-2026 · Cisatracurium besylate

    Subpotent product:out of specification assay results observed during long term stability testing.

    Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial,

  4. March 21, 2025 · Class II · Ongoing · D-0354-2025 · Methocarbamol

    Lack of Assurance of Sterility: Media fill with bacterial contamination

    Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL car

  5. March 21, 2025 · Class II · Ongoing · D-0358-2025 · Haloperidol decanoate

    Lack of Assurance of Sterility: Media fill with bacterial contamination

    Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10

  6. March 21, 2025 · Class II · Ongoing · D-0355-2025 · Haloperidol decanoate

    Lack of Assurance of Sterility: Media fill with bacterial contamination

    Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-381-01 (individual carton) and NDC 70069-381-10 (10x1 mL carton)

2024

  1. December 16, 2024 · Class III · Terminated · D-0169-2025 · Atropine

    Failed Impurities/Degradation Specifications

    Atropine Sulfate Ophthalmic Solution, USP 1%, 5 mL bottles, Rx only, Manufactured for: Somerset Therapeutics, LLC. Somerset, NJ 08873, NDC 70069-716-01

  2. April 24, 2024 · Class II · Ongoing · D-0506-2024 · Haloperidol decanoate

    Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).

    Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC 70069-381-10), Rx only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 3

2020

  1. June 4, 2020 · Class III · Terminated · D-1375-2020 · Brimonidine tartrate

    Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

    Brimonidine Tartrate Opthalmic Solution 0.2%, 15 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-233-01

Show the 2 older recalls

2020

  1. June 4, 2020 · Class III · Terminated · D-1373-2020 · Brimonidine tartrate

    Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

    Brimonidine Tartrate Opthalmic Solution 0.2%, 5 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-231-01

  2. June 4, 2020 · Class III · Terminated · D-1374-2020 · Brimonidine tartrate

    Failed Impurities/Degradation Specification: There is a slow leaching process from the product label on the bottle which may impact the product over the shelf life.

    Brimonidine Tartrate Opthalmic Solution 0.2%, 10 mL bottle, Rx only, Manufactured for: Somerset Therapeutics, LLC Hollywood, FL 33024. Made in India. NDC 70069-232-01

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →